The enzyme kinetics of the amide ligase MurE, a cell wall biosynthesis enzyme, from Pseudomonas aeruginosa were determined using the synthesized nucleotide substrate UDPMurNAc-Ala-Glu . When coupled to a competitive bio-panning technique using a M13 phage display library encoding ∼ 2.7 × 10 9 random peptide permutations and the specific substrates mesoA2pm (meso-diaminopimelic acid) and ATP, a peptide inhibitor of MurE was identified. The MurEp1 dodecamer selected and synthesized inhibited MurE ATPase activity with an IC 50 value of 500 μM. The inhibition was shown to be time-dependent and was reversed by the addition of meso-A2pm or UDP-MurNAcAla-Glu during the pre-incubation step. Kinetic analysis defined MurEp1 as a mixed inhibitor against both substrates with K i values of 160 and 80 μM respectively. MurEp1 was found to interfere in meso-A2pm and UDP-MurNAc-Ala-Glu binding necessary for amide bond formation. Modelling of Ps. aeruginosa MurE and docking of MurEp1 on the Ps. aeruginosa MurE surface indicated that MurEp1 binds at the juxtaposition of both mesoA2pm-and UDP-MurNAc-Ala-Glu-binding sites in the closed conformational state of the enzyme. Identification of the MurEp1 residues involved in MurE binding and inhibition will allow the development of a novel class of inhibitors having a novel mode of action against MurE.
INTRODUCTION
The bacterial cell wall biosynthesis pathway, for peptidoglycan synthesis and assembly, constitutes one of the best targets for the design of new antibacterial agents against the growing problem of antibiotic resistance. The intracellular enzymes MurA-MurF achieve the first step of the pathway by catalysing the synthesis of the precursor UDP-N-acetylmuramyl pentapeptide. These enzymes are essential for bacterial survival; inhibition of one of these enzymes gives a lethal phenotype. Mur enzymes are expressed during infection of the host, are highly conserved among bacteria and have no counterparts in eukaryotes [1, 2] . Although many known antibiotics interfere with enzymes involved in the later steps of peptidoglycan production, few target the enzymes that catalyse the cytoplasmic step. The unavailability of suitable intermediates in vitro has severely hampered kinetic studies and development of inhibitors against these enzymes [2, 3] .
We have selected MurE as a key target enzyme for developing peptide inhibitors. MurE is part of the four ATP-dependent amide ligases that perform the stepwise addition of amino acids (L-Ala, D-Glu, a di-amino acid and D-Ala-D-Ala) to form the cell wall peptide moiety [4] . The non-ribosomal peptide bond formation involves a carboxy group activation of the nucleotide substrate to an acylphosphate intermediate by ATP, followed by nucleophilic attack by the amino group of the condensing amino acid and elimination of the phosphate group [2] . MurE is the only Mur ligase for which amino acid substrate specificity differs among bacterial species. Typically, Gram-negative bacteria and bacilli contain a meso-A2pm (meso-diaminopimelic acid) residue at the third position of the cell wall peptide moiety, whereas Grampositive bacteria contain L-lysine at this position [5, 6] . Addition of the di-amino acid residue at the third position of the cell wall peptide moiety is critical for the formation of the peptide side-chain cross-linkages by the periplasmic transpeptidases, establishing cell shape and integrity [6, 7] . Furthermore, the flexibility of the meso-A2pm-meso-A2pm cross-bridge enables bacteria to adapt the peptidoglycan cross-linkage to growth conditions and environmental changes [7] .
As a model target system, we studied the MurE UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:meso-diaminopimelate ligase from the Gram-negative bacterium Pseudomonas aeruginosa, an opportunistic pathogen highly resistant to most classes of antibiotics [8] . We first synthesized and purified the UDPMurNAc-Ala-Glu (uridine 5 -diphosphoryl N-acetylmuramoyl-L-alanyl-D-glutamate) substrate to study the kinetics of the MurE amide ligase. We then developed a competitive bio-panning phage display screening approach using the substrates meso-A2pm and ATP to identify a peptide inhibitor of MurE. Phage display is a powerful tool for the selection of short peptides that interact specifically with target proteins by using a large pool of random peptide permutations fused to the phage M13 pIII minor coat protein [9] . This approach has been useful for the identification of various peptide inhibitors of enzymes, including MurC and MurD [10, 11] .
Abbreviations used: meso-A2pm: meso-diaminopimelic acid; PFU, plaque-forming unit(s); RMSD, root mean square deviation; UDP-GlcNAc, uridine 5 -diphosphoryl N-acetylglucosamine; UDP-MurNAc-Ala-Glu, uridine 5 -diphosphoryl N-acetylmuramoyl-L-alanyl-D-glutamate. 1 To whom correspondence should be addressed (email rclevesq@rsvs.ulaval.ca).
EXPERIMENTAL

Purification of biologically active MurE enzyme
The MurE protein from Ps. aeruginosa PAO1 was overexpressed, purified and sequenced as described previously [12] . All reagents were purchased from Sigma-Aldrich unless indicated otherwise. The phosphate present in the MurE conservation buffer was removed by dialysing 3 ml three times against 3 litres of buffer A (25 mM Bis-Tris, pH 8, 1 mM 2-mercaptoethanol and 2.5 mM MgCl 2 ) at 4 • C. Purified MurE protein was visualized by SDS/PAGE using SYPRO ® Orange staining (Bio-Rad), and the protein concentration was determined using the Bradford method (Bio-Rad) with BSA as standard. Glycerol was added to the phosphate-free MurE solution to a concentration of 10 % (v/v) and aliquots of 100 μl were conserved at − 20
• C. The biological activity of MurE was assayed by in vitro reconstruction of the biosynthetic pathway of peptidoglycan cytoplasmic precursor in the presence of purified MurA, MurB, MurC, MurD and MurF as described previously [12] .
Synthesis and purification of UDP-MurNAc-Ala-Glu
Synthesis of UDP-MurNAc-Ala-Glu was performed according to the method described previously [13] , except that the synthesis from UDP-GlcNAc (5 -diphosphoryl N-acetylglucosamine) was carried out in a single reaction using the combined activities of Ps. aeruginosa MurA, MurB, MurC and MurD enzymes. The Mur enzymes were removed by ultrafiltration and UDPMurNAc-Ala-Glu was purified by loading the ultrafiltrate into a column packed with DEAE-Sephacel pre-equilibrated in 10 mM ammonium acetate at pH 7.5 and eluting at room temperature (20 • C) with a 10-800 mM ammonium acetate gradient. A pyruvate kinase/lactate dehydrogenase-coupled assay for mesoA2pm-dependent ADP generation by MurE was used to identify fractions containing the cell wall intermediate. Positive fractions were freeze-dried three times to remove ammonium acetate. UDP-MurNAc-Ala-Glu purity was assessed by analytical anionexchange FPLC on MonoQ TM using a 0-0.5 M ammonium acetate gradient. Structure of the purified UDP-MurNAc-Ala-Glu was confirmed using negative-ion electrospray MS, and the product was stored as frozen aqueous solution at 4.34 mM.
Kinetic characterization of MurE activity
The ATPase activity of the Ps. aeruginosa MurE protein was assessed by a spectrophotometric assay that quantifies released inorganic phosphate using the Lanzetta reagent [14] . The reaction was performed in 100 μl of reaction buffer B (50 mM Bis-Tris, pH 8.0, 1 mM dithiothreitol and 5 mM MgCl 2 ) containing 8.7 μ-units of purified MurE (from a fresh aliquot for each assay), 1 mM ATP, 200 μM UDP-MurNAc-Ala-Glu and 10 mM mesoA2pm. The MurE enzyme was allowed to react for 15 min at room temperature before the addition of 800 μl of the Lanzetta reagent. The mixture was incubated for 5 min to allow proper colour development, 100 μl of a 34% (w/v) sodium citrate solution was added and the absorbance was immediately measured at 660 nm with a Cary spectrophotometer (Varian) [14] . The amount of inorganic phosphate was determined by comparison with the linear portion of a phosphate standard curve with a minimum R 2 value of 0.99. The phosphate content of each component in the reaction was determined and subtracted from the total phosphate. Negative controls were performed without enzyme or substrate and assays were carried out in triplicate. Saturation curves were obtained for each substrate individually using fixed and optimal concentrations of the remaining substrates. The following parameters were determined for MurE with respect to each substrate: the k cat , the maximal specific hydrolysis activity, the catalytic-centre activity, the K m and the enzyme efficiency. Kinetic parameters were determined by non-linear regression analysis by means of a square matrix of enzyme velocities based on the Michaelis-Menten equations using the Enzyme Kinetics Module version 1 of SigmaPlot 8.
Affinity selection of phage-displayed peptides against MurE
Phage display screening was performed using the PH.D.-12 M13 phage library containing ∼ 2.7 × 10 9 peptide permutations (New England Biolabs) as described previously [10, 15] . The screening specificity and stringency were optimized by increasing the Tween concentration during washing and by decreasing the time of contact between the phages and the targeted MurE protein during the three rounds of bio-panning. See Table 3 for the phage titres used as input. Phages with encoded peptides were eluted at the third round of bio-panning by 100 μl of 0.2 M glycine/HCl (pH 2.2), 100 μl of 1 mM meso-A2pm or 100 μl of 1 mM ATP for 30 min. The DNA of ten phages was sequenced for each elution condition with a − 96 gIII primer (New England Biolabs). The deduced peptide sequences were aligned and consensus amino acids were identified.
Peptide synthesis
The dodecameric peptide encoded by the strongest consensus sequence selected by the phage display screening (NHNM-HRTTQWPL) was synthesized and purified as described previously [10] . Called MurEp1, its purity (>95 %) was analysed by HPLC and its molecular mass (1534.74 Da) was confirmed by MALDI-TOF-MS (matrix-assisted laser-desorption ionizationtime-of-flight MS). The peptide was dissolved in buffer C (200 mM Tris/HCl, pH 8) at a concentration of 100 mM and the pH was adjusted to 7.0.
Bioinformatics analysis
The peptide consensus sequence was characterized using the Compute pI/Mw and ProtParam algorithms [16] as well as the PSIpred and SSpro secondary-structure prediction tools of the ExPasy proteomics server [17] [18] [19] . The sequence was also analysed for homologues in the UniProt database using the fasts34 program [11] .
Evaluation of MurEp1 as an inhibitor of MurE ATPase activity
Inhibition of MurE ATPase activity by MurEp1 was observed at room temperature in reaction buffer B using the spectrometrybased method described above. Substrates were added after preincubation of the enzyme with the inhibitor. A test was carried out with 750 μM MurEp1 for 0, 10, 30, 60 or 120 min of preincubation to observe possible time-dependence of inhibition. Assays were also performed in which one substrate was added for 30 min of pre-incubation with or without 750 μM MurEp1. MurE specific activities were determined in the presence of 75, 150 or 600 μM MurEp1 with pre-incubation periods of 10 and 30 min and were compared with the reference activity without inhibitor. MurEp1 K i was determined for meso-A2pm and UDP-MurNAcAla-Glu using reaction velocity data obtained with 75, 150 and 600 μM MurEp1 (with a 30 min pre-incubation) and either five concentrations of meso-A2pm (0.075, 0.25, 0.75, 3 and 10 mM) or five concentrations of UDP-MurNAc-Ala-Glu (12.5, 25, 50, 100 and 200 μM) with fixed optimal concentrations of the other substrates. K i values were determined regardless of the inhibition type, based on the following equation:
where α is the K m factor change when MurEp1 is bound to the enzyme-substrate complex, β is the K p factor change when MurEp1 is bound to the enzyme-substrate complex, I is the inhibitor concentration and S is the substrate concentration.
All experiments were carried out in triplicate. Kinetic data were fitted to the appropriate model equations using the Enzyme Kinetics Module of SigmaPlot. Steady-state inhibition kinetic parameters were determined by non-linear regression analysis using the least-squares method as a quality control to ensure accurate dataset fitting and to generate error estimates. The expected K m values for the inhibited MurE reactions were calculated from an increase in the uninhibited K m value by a factor of 1 + [MurEp1]/K i for meso-A2pm and 1 + [MurEp1]/3K i for UDP-MurNAc-Ala-Glu [20, 21] . As controls, non-specific peptides issued from phage display were tested at different concentrations for inhibition of MurE activity [22] .
Computer-assisted modelling of MurE and docking of MurEp1
Modelling of MurEp1 was performed using BetaTPred2 [23] ; the peptide contains a β-turn as do many antibacterial peptides. The model of MurEp1 was built from the NMR structure (PDB:1WR3) using the first WW (Trp-Trp) domain of ubiquitinprotein ligase Nedd4-2 [24] with the nest modelling software from the Jackal package (available at http://wiki.c2b2.columbia. edu/honiglab_public/index.php/Software:Jackal); the interactions between MurEp1 and MurE were extracted using PIC software [25, 26] . Alignment of both peptide sequences was done using the water algorithm from EMBOSS [27] . The secondary structure for the three-dimensional model was extracted using Stride [28] , and the MurEp1 structure was refined using the minst software from the Jackal package [25, 26] . The MurEp1 docking in MurE was carried out using Patchdock [29] , and the structure was refined with Firedock [30] . Parameters used were: clustering RMSD (root mean square deviation) of 4.0 Å (1Å = 0.1 nm), complex type of enzyme inhibitors with 50 RBO (rigid body optimization) cycles and an atomic radius scale of 0.8. The quality of the MurE model was confirmed using procheck [31] , and the localization of amino acids in the model was confirmed using Verify-3D [32] .
RESULTS
Purification of biologically active MurE
The purified MurE protein was visualized as a single 55 kDa molecular mass band on SDS/PAGE (results not shown). Sequencing of the first 15 N-terminal residues confirmed its identity as MurE from Ps. aeruginosa (identical with the published sequence). Its biological activity was confirmed by reconstruction of the cell wall precursor UDP-N-acetylmuramyl pentapeptide in the presence of MurA, MurB, MurC, MurD and MurF [12] .
Synthesis and purification of the UDP-MurNAc-Ala-Glu substrate
Analysis by anion-exchange chromatography indicated that the UDP-MurNAc-Ala-Glu product was 99.5 % pure ( Figure 1A ). Characterization of the purified product by MS identified four different species with observed m/z values identical with the expected values (Table 1) . Results obtained confirmed the UDPMurNAc-Ala-Glu structure as presented in Figure 1 (B).
MurE amide ligase activity
A series of preliminary experiments defined optimal conditions for the MurE assay as 15 min at room temperature in buffer B. Addition of NaCl did not improve MurE activity (results not shown). As depicted in Figure 2 (A), the optimal concentration of ATP was 1 mM, whereas a concentration of 2 mM decreased MurE specific activity. The maximal specific activity was reached at 10 mM meso-A2pm ( Figure 2B ). The optimal concentration of UDP-MurNAc-Ala-Glu was 200 μM and concentrations of 300 μM or greater decreased enzyme activity ( Figure 2C ). On the basis of K m values, the affinity of MurE for UDP-MurNAcAla-Glu was approx. 4.5-fold higher than for meso-A2pm and approx. 7.5-fold higher than for ATP ( Table 2 ). The catalyticcentre activity values indicated that each MurE active site hydrolysed 2.3 ATP molecules/s to ADP and inorganic phosphate and thus performed 2.3 amide ligase reactions/s between mesoA2pm and UDP-MurNAc-Ala-Glu according to the demonstrated stoichiometric relationship [33] . The enzyme efficiency indicated that MurE was more efficient with respect to UDP-MurNAcAla-Glu. The kinetic parameters were measured with reasonable precision, having S.D. values of less than 30 %.
Selection of specific MurE-binding peptides
As shown in Table 3 , each round of bio-panning enriched for MurE-specific-binding peptides, phage titres decreasing from approx. 10 11 to 10 5 PFU (plaque-forming units). Each round of bio-panning yielded a lower phage recovery in comparison with the previous round. This effect was more pronounced for the third round, indicating the strongest selection of specific MurEinteracting peptide sequences at this step. Each elution strategy gave similar phage recovery yields, indicating that competitive elutions were as selective and potent as the standard glycine elution. Sequencing of ten phages selected from each of the three elution strategies identified a variety of peptide sequences containing consensus motifs (Figure 3 ). Analysis of frequencies of the similar peptides obtained gave the consensus sequence NHNM-HRTTQWPL recovered mainly by the meso-A2pm competitive elution. The ATP competitive elution selected several peptide sequences presenting conserved residues of this consensus sequence. The MHR (Met-His-Arg) motif found in the consensus sequence was predominant in the selected peptides, including a variation with two basic residues next to a hydrophobic residue. The consensus sequence had a large proportion of polar and basic amino acids (Figure 3 ). In addition to the consensus sequence, several sequences (indicated by the superscripts a, b, c and d in Figure 3 ) were recovered more than once. The glycine elution also recovered a sequence that differed from sequence c (Figure 3 ) by one residue, three peptides having an EGRP (Glu-Gly-ArgPro) motif, four peptides starting with a lysine residue and three peptides containing two proline residues followed by a TRS (Thr-Arg-Ser) motif. The ATP competitive elution gave a larger diversity of peptide sequences than the other elution conditions.
Peptide analysis
The theoretical pI of the consensus peptide sequence was established at 9.8, indicating that the peptide is positively charged at neutral pH. The consensus sequence does not contain any negatively charged residues and contains one positively charged residue. ProtParam confirmed the high proportion of asparagine, histidine and theronine residues in the consensus sequence and estimated the half-life of the peptide at more than 10 h in Escherichia coli and at 1.4 h in mammalian reticulocytes in vitro. The secondary-structure prediction indicated a putative random coil structure. Fasts34 did not identify peptide homologues having an E value <5 in the UniProt database.
Kinetics of MurE inhibition by MurEp1
As shown in Figure 4(A) , the residual activity of MurE decreased exponentially when the pre-incubation time with MurEp1 increased, indicating that the inhibition is time-dependent. The IC 50 values for MurEp1 determined with pre-incubation periods of 10 and 30 min were 800 and 500 μM respectively ( Table 4) . The specific activity of MurE decreased gradually as a function of the MurEp1 concentration, giving an inverse linear doseresponse with a varying slope ( Figure 4B ). Meso-A2pm or UDP-MurNAc-Ala-Glu added during the 30 min pre-incubation period completely restored MurE activity, whereas adding ATP did not affect inhibition by MurEp1 (results not shown). MurE reaction velocity was identical with or without UDP-MurNAc-Ala-Glu in the pre-incubation step, but was slightly reduced in the presence of ATP or meso-A2pm. This effect (Table 4) . Even if MurEp1 behaved as a time-dependent inhibitor, the tight binding inhibition model was excluded since the MurE concentration was not approximately equal to or higher than the apparent K i values. The α parameter indicated that binding of MurEp1 to the enzymesubstrate complex decreased MurE affinity for meso-A2pm by a factor of 3, and decreased the MurE affinity for UDP-MurNAcAla-Glu by a factor of 6 ( Table 4 ). The β parameters indicated that the dissociation of the enzyme-substrate complex to enzyme and product was slightly affected by MurEp1 in the case of the meso-A2pm complex, and strongly inhibited in the case of the UDP-MurNAc-Ala-Glu (Table 4) .
The V max values for MurE decreased as a function of MurEp1 concentration with respect to meso-A2pm; the V max obtained with 600 μM of MurEp1 was half of the typical value. This effect was not observed for UDP-MurNAc-Ala-Glu ( 
Computer-assisted modelling of MurE and docking of MurEp1
The structure of the Ps. aeruginosa MurE enzyme was modelled from the structural data of its E. coli counterpart. The majority of the amino acid residues forming the active site of MurE are conserved in Ps. aeruginosa and E. coli, with the exception of the loop at positions 42-47 in the E. coli MurE which interacts with pyrophosphate of the UDP-MurNAc-Ala-Glu-meso-A2pm product, and Asn 156 , which is replaced by His 150 , in the Ps. aeruginosa MurE (Figures 6A and 6B ). The quality of the Ps. aeruginosa MurE model was confirmed using procheck [31] , and the Ramachandran plot showed 99.2 % of residues positioned correctly in the model. The localization of amino acid residues in the model was confirmed using Verify-3D [32] , giving an average 3D-1D (three-dimensional and primary structure comparisons) of 91.14 %. Alignment with E. coli MurE gave an RMSD of 0.2 Å for 457 amino acids.
The MurEp1 inhibitor was successfully docked into the structure of Ps. aeruginosa MurE. According to the model presented in Figure 6 , MurEp1 binds to the active site of MurE that assembled at the common domain interfaces. The predicted MurEp1-binding site overlapped with the meso-A2pm and UDP-MurNAc-Ala-Glu substrate-binding sites in the closed conformational state of the enzyme (Figures 6A and 6B) . The docking also suggested that MurEp1 was close enough to the shape and size of both meso-A2pm and UDP-MurNAc-Ala-Glu to compete for their binding sites on the enzyme surface ( Figure 6B) .
The specific residues involved in the Ps. aeruginosa MurEMurEp1 molecular interactions are presented in Figure 6 (C) and indicate that MurEp1 binds to MurE via three pairs of residues. The two N-terminal pairs are composed of the residues at positions one and two in the peptide sequence (Asp-His) and the residues at positions four and five (Asp-His). These four residues allow the binding of MurEp1 to the meso-A2pm-binding site of MurE in close proximity to the UDP-MurNAc-Ala-Glu-binding site. The third pair of residues, composed of the C-terminal tryptophan and proline residues at positions 10 and 11, allow the binding of MurEp1 to the UDP-MurNAc-Ala-Glu-binding site on MurE (Figure 6 ). 457 , and it has been shown to interact with the meso-A2pm moiety of the UDPMurNAc-Ala-Glu-meso-A2pm product [34] . This indicates that MurEp1 interacts with at least one residue of Ps. aeruginosa MurE directly involved in the binding of the meso-A2pm. His 43 , Gln 44 and Ala 45 of E. coli MurE interact with the UDP-MurNAc moiety of the UDP-MurNAc-Ala-Glu-meso-A2pm product, but they are not conserved in the Ps. aeruginosa MurE. According to the modelling of Ps. aeruginosa MurE (Figures 6A and 6B ), Val 37 of Ps. aeruginosa MurE may be involved in the interaction with the UDP-MurNAc moiety. This residue interacts with the C-terminal proline residue of MurEp1, suggesting that MurEp1 may bind to a residue directly involved in the binding of the nucleotide substrate. Modelling of Ps. aeruginosa MurE also indicates that Leu 23 that interacts with the C-terminal Trp-Pro residues of MurEp1 may also be involved in the binding of the nucleotide substrate of MurE.
DISCUSSION
The lack of commercially available pathway intermediates suitable for kinetic analysis and studies of inhibitors have severely hampered the discovery and characterization of inhibitors of the MurE amide ligase, a potent antibacterial target. We synthesized the UDP-MurNAc-Ala-Glu substrate of the enzyme ( Figure 1 and Table 1 ). Biologically active MurE from Ps. aeruginosa was purified and detailed kinetic analysis was carried out by monitoring the release of inorganic phosphate for MurE ATPase activity. The MurE ATPase activity has been shown to be absolutely dependent on the di-amino acid and UDP-MurNAcAla-Glu substrates [33] . The vast majority of MurE kinetic studies have measured enzyme activity using addition of radioactive diamino acid substrate to UDP-MurNAc-Ala-Glu, and quantifying the radioactive UDP-MurNAc-tripeptide after separation by reverse-phase HPLC, HPLC cation-exchange chromatography, high-voltage electrophoresis or TLC [6, 33, [35] [36] [37] [38] [39] [40] [41] . Compared with our simple, rapid and sensitive spectrophotometric assay, these methods are time-consuming, costly and labour-intensive. A MurE ATPase assay based on the ADP-and NAD-coupled reaction with pyruvate kinase and lactate dehydrogenase has been reported [42] . Our assay measures ATP hydrolysis directly rather than through an NAD-dependent additional enzymatic reaction, thus offering better screening capacities to analyse specific MurE inhibitors. Furthermore, our assay could be easily adapted to HTS (high-throughput screening) in microtitre plates. Recently, Bratkovi et al. [43] reported a similar assay, quantifying the release of inorganic phosphate with the Biomol Green reagent.
A high concentration of ATP was detrimental to MurE activity ( Figure 2A) ; this has been observed previously with the Staphylococcus aureus MurE enzyme [33] . MurE is highly sensitive to pH: a pH value of 8.5 has been found to be optimal and enzyme activity ceases below pH 7 [33, 44, 45] . A UDP-MurNAcAla-Glu concentration above 300 μM caused strong substrate inhibition of MurE activity ( Figure 2C) ; this has also been observed with MurE from Thermotoga maritima, S. aureus and Bacillus cereus [33, 44, 45] . Similar inhibition by the nucleotide cell wall precursor has been noted for the cell wall biosynthesis enzymes MurA and MurF [46, 47] . Adding NaCl did not suppress substrate inhibition for MurE as it does for the MurF enzyme [46] . Such substrate inhibition is presumably involved in regulation of the cell wall synthesis rate, allowing cells to respond to different growth and environmental conditions. The optimal substrate concentrations and K m values obtained for Ps. aeruginosa MurE were similar to those obtained for other MurE enzymes. The K m values obtained for UDP-MurNAc-Ala-Glu and meso-A2pm (Table 2) were nearly identical and higher respectively than those reported for the E. coli enzyme: 35 μM for UDP-MurNAc-AlaGlu and 36 μM for meso-A2pm [36] ; 76 μM for UDP-MurNAcAla-Glu and 36 μM for meso-A2pm [48] ; 55 μM for UDPMurNAc-Ala-Glu [49] ; and 40 μM and 11 μM for meso-A2pm [39, 50] . The Ps. aeruginosa MurE K m values were similar to those obtained for the B. cereus meso-A2pm-adding enzyme: 340, 320 and 130 μM for ATP, meso-A2pm and UDP-MurNAc-Ala-Glu respectively [44] . The T. maritima MurE enzyme showed higher K m values; 3.6 mM for ATP, 2.8 mM for L-lysine, 4.8 mM for meso-A2pm and 0.45 mM for UDP-MurNAc-Ala-Glu [45] . The Ps. aeruginosa MurE V max of 2.7 μmol/min per mg was close to 3.31 μmol/min per mg for this species [42] , higher than for its E. coli counterpart (1.8 and 32 nmol/min) [36, 39] and lower than for MurE of T. maritima (55 μmol/min per mg) [45] . As with MurE from T. maritima, the Ps. aeruginosa MurE was more efficient with UDP-MurNAc-Ala-Glu [45] .
Limiting the time of contact between the phages and MurE during the third round of bio-panning represented a more stringent selection factor for phage specifically binding to MurE than increasing the wash stringency during the second round. This was indicated by the lower percentages of phages obtained in the third round (Table 3 ). This selection pattern had also been observed in phage display screening of peptides against MurD [11] . In contrast, screening of MurC gave higher phage recovery titres for the second and third rounds [10] . Earlier selection of MurC-specific peptides during the phage display screening compared with MurE and MurD could explain this enrichment [10, 11] . It should also be noted that several other factors affect phage recovery, such as phage infection and replication efficiency, protein translocation and folding bias as well as pIII coat stability [51] .
The synthesized MurEp1 peptide encoding the strongest consensus sequence selected by the phage display screening represented a potent and specific time-dependent inhibitor of the essential ATPase activity of MurE (Figure 4) . The most conserved residues of the MurEp1 sequence would probably be essential for MurE binding and inhibition. Indeed, the histidine residues of MurEp1 are particularly conserved and are predicted to interact directly with MurE residues (Figure 3 and Figure 6C ). The K i values determined for MurEp1 with meso-A2pm and UDPMurNAc-Ala-Glu (Table 4) indicated that MurEp1 is a reversible inhibitor sharing properties of competitive and non-competitive inhibitors. MurEp1 acted as a competitive inhibitor since the inhibition was reversed by addition of meso-A2pm or UDPMurNAc-Ala-Glu during pre-incubation, giving very similar y-intercepts for all MurEp1 concentrations on the LineweaverBurk plot in the case of UDP-MurNAc-Ala-Glu ( Figure 5B (Table 4) [20, 21] . Similar to a noncompetitive inhibitor, that interferes with substrate without competing directly for the substrate-binding site, MurEp1 inhibited MurE at high or low substrate concentrations. The V max of MurE decreased as a function of MurEp1 concentration for meso-A2pm and the y-intercept of the Lineweaver-Burk plot varied in the case of meso-A2pm ( Figure 5A and Table 4 ). Overall, the kinetic data indicated that MurEp1 inhibited the proper binding of the meso-A2pm and UDP-MurNAc-Ala-Glu substrates to their respective binding sites on the surface of MurE, thus interfering with amide bond formation between the substrates.
MurEp1 acted as a mixed inhibitor of meso-A2pm, and a reduction in the V max of MurE was observed as a function of MurEp1 concentration. This may be caused by the inhibitory effect of MurEp1 on the utilization of the UDP-MurNAc-Ala-Glu substrate by MurE. MurEp1 appeared to be a stronger inhibitor in regard to the UDP-MurNAc-Ala-Glu substrate, as the binding of MurEp1 to the enzyme-substrate complex decreased MurE affinity for UDP-MurNAc-Ala-Glu 2-fold more efficiently than for meso-A2pm. Furthermore, MurEp1 strongly inhibited the conversion of bound substrate into product in the case of UDPMurNAc-Ala-Glu, whereas it is slightly affected in the case of the meso-A2pm complex ( Table 4) .
The crystal structure of E. coli MurE has revealed that the enzyme has a three-domain topology. UDP-MurNAc-Ala-Glu binds in the N-terminal domain (domain 1), ATP binds principally to the central portion of MurE (domain 2) and meso-A2pm interacts with the C-terminus (domain 3) [34] . For ligation to occur between UDP-MurNAc-Ala-Glu and meso-A2pm, the open substrate-free MurE must undergo an important conformational change to bring together and correctly orient both substrates for acyl-phosphate intermediate formation, after the binding of ATP. Then, MurE must orient meso-A2pm for nucleophilic attack and stabilize the tetrahedral intermediate, thereby lowering the activation barrier and accelerating catalysis [34] . The threedimensional structure of MurE thus excludes the possibility of the MurEp1 peptide binding at the juxtaposition of both meso-A2pm-and UDP-MurNAc-Ala-Glu-binding sites on the open substratefree MurE. However, MurEp1 may have independent affinities for both binding sites. Since MurEp1 was originally selected by competitive elution with the meso-A2pm substrate on the open form of MurE, MurEp1 and meso-A2pm probably target the same binding site at the C-terminal domain of MurE. We thus presume that MurEp1 recognizes the meso-A2pm-binding site on the open form of MurE. Computer-assisted modelling of Ps. aeruginosa MurE and docking of MurEp1 indicated that MurEp1 binds at the juxtaposition of both meso-A2pm-and UDP-MurNAc-AlaGlu-binding sites in the closed conformation of MurE ( Figure 6 ). MurEp1 may first bind to the meso-A2pm-binding site on the open form of MurE and interact further with the active site and the UDPMurNAc-Ala-Glu-binding site following conformational changes and formation of the closed form of MurE ( Figure 6C ). The co-crystallization of the MurEp1-MurE complex will be needed to determine whether MurEp1 specifically recognizes the UDPMurNAc-Ala-Glu-binding site on the closed conformation or whether it also recognizes the site on the open form of MurE. In either case, the MurEp1 peptide inhibits the MurE amide ligase reaction by hampering proper interactions between the mesoA2pm and UDP-MurNAc-Ala-Glu substrates and the enzyme, and by preventing utilization of UDP-MurNAc-Ala-Glu.
The Mur ligase enzymes belong to a well-defined class of proteins that are closely related functionally [52] . As each amide ligase displays high specificity for its respective substrates with no cross-activity [4] , we hypothesize that MurEp1 is a specific inhibitor of MurE. Phage display screenings performed on the MurC, MurD and MurE amide ligases of Ps. aeruginosa using similar experimental conditions did not identify redundant peptide sequences [10, 15] . Few MurE inhibitors have been reported to date and none of them has antibacterial activity [2] . The most potent compound is a phosphinate inhibitor, which interferes with the tetrahedral intermediate of MurE and inhibited MurE with an IC 50 value of 1.1 μM [37] . Two analogous substrates close to the natural UDP-MurNAc-Ala-Glu substrate have a significant inhibitory effect on MurE at 1 mM, with the best inhibitor giving a MurE residual activity of 71 % [49] . Recently, phosphinate transition-state inhibitors of MurD were shown to inhibit MurE, acting as UDP-MurNAc-Ala-Glu substrate analogues. The more promising compound gave a MurE residual activity of 12 % at a concentration of 1 mM [41] . Several analogues of mesoA2pm have been tested as competitive inhibitors of MurE [2] . The LD diastereoisomers of N-α-propionyl-dipeptides displayed moderate inhibitor effects [53] ; (2S,3R,6S)-3-fluoro-A2pm and Nhydroxy-A2pm respectively had IC 50 values of 2.3 and 0.56 mM with an expected K i value of 0.4 mM for N-hydroxy-A2pm [40] , while a monophosphonomonocarboxy analogue had an IC 50 value of 10 mM [38] . The MurEp1 peptide does not have structural homology with these meso-A2pm analogues, and was shown to be a more potent inhibitor (Table 4) .
During the course of the present work, Bratkovič et al. [43] performed a phage display screening against MurD from E. coli and MurE from S. aureus. After three rounds of bio-panning, elution of MurE-specific peptides was performed with UDPMurNAc-Ala-Glu, L-lysine and glycine. Ten phages were sequenced and no clear amino acid motif was identified, but four prevalent peptides were synthesized. The three dodecameric peptides were shown to be inactive, whereas the cyclic C7C peptide CQANLRSQC inhibited the ATPase activity of MurE with an IC 50 value of 1100 μM [43] . Peptides selected against MurD from E. coli have no similarity to those identified previously [11] . Peptides selected against MurE from S. aureus display few resemblances with the peptide sequences reported in Figure 3 . For comparative purposes, it should be noted that MurE from Ps. aeruginosa and S. aureus recognize different di-amino acid substrates. The dodecamer ME-12_2 selected by Bratkovič et al. [43] begins with THLP (Thr-His-Lys-Pro), whereas two peptide sequences from the glycine elution and one from the ATP elution reported in the present study begin with TGLP (Thr-Gly-Lys-Pro). The dodecamer ME-12_3 begins with SYS (Ser-Tyr-Ser) and one peptide sequence selected with the ATP competitive elution begins with SFS (Ser-Phe-Ser) (Figure 3) . In an attempt to achieve a conformational homogeneous population of target enzymes during the screening process, Bratkovič et al. [43] exposed MurD and MurE to the ATP substrate. ATP binding initiates the conformational change of the Mur ligases, but these enzymes assemble into an active closed tertiary structure only when the three substrates are bound [34, [54] [55] [56] . The MurD and MurE enzymes used by Bratkovič et al. [43] were likely to be present as a transitional tertiary structure state.
We have identified and characterized the first dodecameric peptide inhibitor of the MurE cell wall biosynthesis enzyme. The peptide has a novel mode of action against the amide ligase, binding at the juxtaposition of both meso-A2pm-and UDPMurNAc-Ala-Glu-binding sites in the closed conformation of the enzyme and preventing amide bond formation. Identification of the MurEp1 residues involved in MurE binding and inhibition will allow the development of optimized inhibitors by peptidomimetism. This is of particular interest because targeting MurE may also lead to perturbation in the regulation of antibiotic resistance. MurE has previously been shown to influence methicillin resistance in S. aureus by regulating the expression of two penicillin-binding proteins [57, 58] .
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